ENTRY       D03820                      Drug
NAME        Dutasteride (JAN/USP/INN);
            Avodart (TN)
PRODUCT     AVODART (Woodward Pharma Services LLC)
  GENERIC   DUTASTERIDE (Amneal Pharmaceuticals LLC)
            DUTASTERIDE (Aurobindo Pharma Limited)
            DUTASTERIDE (Bryant Ranch Prepack)
            DUTASTERIDE (Bryant Ranch Prepack)
            DUTASTERIDE (Bryant Ranch Prepack)
            DUTASTERIDE (Bryant Ranch Prepack)
            DUTASTERIDE (Camber Pharmaceuticals)
            DUTASTERIDE (Epic Pharma)
            DUTASTERIDE (Golden State Medical Supply)
            DUTASTERIDE (Humanwell PuraCap Pharmaceutical (Wuhan))
            DUTASTERIDE (MARKSANS PHARMA LIMITED)
            DUTASTERIDE (NuCare Pharmaceuticals)
            DUTASTERIDE (Proficient Rx LP)
            DUTASTERIDE (Proficient Rx LP)
            DUTASTERIDE (PuraCap Pharmaceutical LLC)
            DUTASTERIDE (Strides Pharma Science Limited)
            DUTASTERIDE (Viona Pharmaceuticals)
            DUTASTERIDE (XLCare Pharmaceuticals)
            DUTASTERIDE (Zydus Lifesciences Limited)
FORMULA     C27H30F6N2O2
EXACT_MASS  528.2211
MOL_WEIGHT  528.5297
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      Therapeutic category: 2499
            ATC code: G04CB02
            Product: D03820<JP/US>
            Product (mixture): D11389<US>
EFFICACY    Prostatic hyperplasia treatment, Antiandrogen, 5alpha-Reductase inhibitor
COMMENT     Treatment of benign prostatic hyperplasia
TARGET      SRD5A1 [HSA:6715] [KO:K12343]
            SRD5A2 [HSA:6716] [KO:K12344]
  PATHWAY   hsa00140(6715+6716)  Steroid hormone biosynthesis
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
                G04CB Testosterone-5-alpha reductase inhibitors
                 G04CB02 Dutasteride
                  D03820  Dutasteride (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genitourinary Agents
              Benign Prostatic Hypertrophy Agents
               Dutasteride
                D03820  Dutasteride (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D03820  Dutasteride (JAN/USP/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D03820  Dutasteride
              DG02925  CYP3A5 substrate
               D03820  Dutasteride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Dehydrogenases
                SRD5A1
                 D03820  Dutasteride (JAN/USP/INN) &lt;JP/US&gt;
                SRD5A2
                 D03820  Dutasteride (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03820
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03820
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03820
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03820
DBLINKS     CAS: 164656-23-9
            PubChem: 17397907
            ChEBI: 521033
            LigandBox: D03820
ATOM        37
            1   C2x C    28.5514  -21.3770
            2   C5x C    28.5514  -22.7540
            3   N1x N    29.7439  -23.4425
            4   C1y C    30.9364  -22.7540
            5   C1z C    30.9364  -21.3770
            6   C2x C    29.7439  -20.6885
            7   C1x C    32.1289  -23.4425
            8   C1x C    33.3214  -22.7540
            9   C1y C    33.3214  -21.3770
            10  C1y C    32.1289  -20.6885
            11  C1y C    34.5140  -20.6885
            12  C1z C    34.5140  -19.3115
            13  C1x C    33.3214  -18.6230
            14  C1x C    32.1289  -19.3115
            15  C1x C    36.8990  -20.6885
            16  C1x C    36.8990  -19.3115
            17  C1y C    35.7065  -18.6230
            18  C5a C    35.7065  -17.2460
            19  N1b N    36.9030  -16.5552
            20  O5a O    34.5180  -16.5597
            21  C8y C    38.0809  -17.2353
            22  C8x C    38.0810  -18.6227
            23  C8y C    39.2735  -19.3111
            24  C8x C    40.4660  -18.6226
            25  C8x C    40.4660  -17.2352
            26  C8y C    39.2734  -16.5468
            27  C1d C    39.2734  -15.1698
            28  X   F    40.6504  -15.1698
            29  X   F    39.2734  -13.7928
            30  X   F    37.8964  -15.1698
            31  C1d C    39.2735  -20.6881
            32  X   F    37.8964  -20.6881
            33  X   F    40.6505  -20.6881
            34  X   F    39.2735  -22.0651
            35  O5x O    27.3589  -23.4425
            36  C1a C    30.9364  -20.0000
            37  C1a C    34.5140  -17.9345
BOND        41
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 1
            20   12  17 1
            21   17  18 1 #Up
            22   18  19 1
            23   18  20 2
            24   19  21 1
            25   21  22 2
            26   22  23 1
            27   23  24 2
            28   24  25 1
            29   25  26 2
            30   21  26 1
            31   26  27 1
            32   27  28 1
            33   27  29 1
            34   27  30 1
            35   23  31 1
            36   31  32 1
            37   31  33 1
            38   31  34 1
            39    2  35 2
            40    5  36 1 #Up
            41   12  37 1 #Up
///
